 | • レポートコード：MRC2012A5408 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、104ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、遺伝子治療におけるレンチウイルスベクターの世界市場を広く調査・分析し、今後の市場展望をまとめております。遺伝子治療におけるレンチウイルスベクターの種類別市場規模（レトロウイルス（RV）、アデノウイルス（AdV）、アデノ随伴ウイルス（AAV））、用途別市場規模（病院、診療所、研究機関、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Thermo Fisher Scientific Sirion-Biotech GmbH、GENEMEDI、SignaGen Laboratories、Vigene Biosciences、GenTarget、OriGene Technologies、Cell Biolabs、Takara Bio、Bluebird Bio、 ・地域別グローバル市場分析 2015年-2020年 ・遺伝子治療におけるレンチウイルスベクターの北米市場（アメリカ、カナダ、メキシコ） ・遺伝子治療におけるレンチウイルスベクターのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・遺伝子治療におけるレンチウイルスベクターのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・遺伝子治療におけるレンチウイルスベクターの南米市場（ブラジル、アルゼンチン） ・遺伝子治療におけるレンチウイルスベクターの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：レトロウイルス（RV）、アデノウイルス（AdV）、アデノ随伴ウイルス（AAV） ・用途別分析：病院、診療所、研究機関、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Lentiviral Vector In Gene Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Lentiviral Vector In Gene Therapy market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx%% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
Market segmentation
Lentiviral Vector In Gene Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Lentiviral Vector In Gene Therapy market has been segmented into
Retrovirus (RV)
Adenovirus (AdV)
Adeno-associated Virus (AAV)
By Application, Lentiviral Vector In Gene Therapy has been segmented into:
Hospital
Clinic
Research Institution
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Lentiviral Vector In Gene Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level Lentiviral Vector In Gene Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Lentiviral Vector In Gene Therapy market.
The report offers in-depth assessment of the growth and other aspects of the Lentiviral Vector In Gene Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Lentiviral Vector In Gene Therapy Market Share Analysis
Lentiviral Vector In Gene Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Lentiviral Vector In Gene Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Lentiviral Vector In Gene Therapy sales, revenue and market share for each player covered in this report.
The major players covered in Lentiviral Vector In Gene Therapy are:
Thermo Fisher Scientific Sirion-Biotech GmbH
GENEMEDI
SignaGen Laboratories
Vigene Biosciences
GenTarget
OriGene Technologies
Cell Biolabs
Takara Bio
Bluebird Bio
Among other players domestic and global, Lentiviral Vector In Gene Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lentiviral Vector In Gene Therapy product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Lentiviral Vector In Gene Therapy, with price, sales, revenue and global market share of Lentiviral Vector In Gene Therapy in 2018 and 2019.
Chapter 3, the Lentiviral Vector In Gene Therapy competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lentiviral Vector In Gene Therapy breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Lentiviral Vector In Gene Therapy market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Lentiviral Vector In Gene Therapy sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Lentiviral Vector In Gene Therapy Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Lentiviral Vector In Gene Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Retrovirus (RV)
1.2.3 Adenovirus (AdV)
1.2.4 Adeno-associated Virus (AAV)
1.3 Market Analysis by Application
1.3.1 Overview: Global Lentiviral Vector In Gene Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Research Institution
1.3.5 Others
1.4 Overview of Global Lentiviral Vector In Gene Therapy Market
1.4.1 Global Lentiviral Vector In Gene Therapy Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Thermo Fisher Scientific Sirion-Biotech GmbH
2.1.1 Thermo Fisher Scientific Sirion-Biotech GmbH Details
2.1.2 Thermo Fisher Scientific Sirion-Biotech GmbH Major Business
2.1.3 Thermo Fisher Scientific Sirion-Biotech GmbH SWOT Analysis
2.1.4 Thermo Fisher Scientific Sirion-Biotech GmbH Product and Services
2.1.5 Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 GENEMEDI
2.2.1 GENEMEDI Details
2.2.2 GENEMEDI Major Business
2.2.3 GENEMEDI SWOT Analysis
2.2.4 GENEMEDI Product and Services
2.2.5 GENEMEDI Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 SignaGen Laboratories
2.3.1 SignaGen Laboratories Details
2.3.2 SignaGen Laboratories Major Business
2.3.3 SignaGen Laboratories SWOT Analysis
2.3.4 SignaGen Laboratories Product and Services
2.3.5 SignaGen Laboratories Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Vigene Biosciences
2.4.1 Vigene Biosciences Details
2.4.2 Vigene Biosciences Major Business
2.4.3 Vigene Biosciences SWOT Analysis
2.4.4 Vigene Biosciences Product and Services
2.4.5 Vigene Biosciences Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 GenTarget
2.5.1 GenTarget Details
2.5.2 GenTarget Major Business
2.5.3 GenTarget SWOT Analysis
2.5.4 GenTarget Product and Services
2.5.5 GenTarget Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 OriGene Technologies
2.6.1 OriGene Technologies Details
2.6.2 OriGene Technologies Major Business
2.6.3 OriGene Technologies Product and Services
2.6.4 OriGene Technologies Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Cell Biolabs
2.7.1 Cell Biolabs Details
2.7.2 Cell Biolabs Major Business
2.7.3 Cell Biolabs Product and Services
2.7.4 Cell Biolabs Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Takara Bio
2.8.1 Takara Bio Details
2.8.2 Takara Bio Major Business
2.8.3 Takara Bio Product and Services
2.8.4 Takara Bio Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bluebird Bio
2.9.1 Bluebird Bio Details
2.9.2 Bluebird Bio Major Business
2.9.3 Bluebird Bio Product and Services
2.9.4 Bluebird Bio Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Lentiviral Vector In Gene Therapy Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Lentiviral Vector In Gene Therapy Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Lentiviral Vector In Gene Therapy Manufacturer Market Share in 2019
3.3.2 Top 6 Lentiviral Vector In Gene Therapy Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Lentiviral Vector In Gene Therapy Sales, Revenue and Market Share by Regions
4.1.1 Global Lentiviral Vector In Gene Therapy Sales and Market Share by Regions (2015-2020)
4.1.2 Global Lentiviral Vector In Gene Therapy Revenue and Market Share by Regions (2015-2020)
4.2 North America Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
4.3 Europe Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
4.5 South America Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Lentiviral Vector In Gene Therapy Sales, Revenue and Market Share by Country
5.1.1 North America Lentiviral Vector In Gene Therapy Sales and Market Share by Country (2015-2020)
5.1.2 North America Lentiviral Vector In Gene Therapy Revenue and Market Share by Country (2015-2020)
5.2 United States Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
5.3 Canada Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
5.4 Mexico Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Lentiviral Vector In Gene Therapy Sales, Revenue and Market Share by Country
6.1.1 Europe Lentiviral Vector In Gene Therapy Sales and Market Share by Country (2015-2020)
6.1.2 Europe Lentiviral Vector In Gene Therapy Revenue and Market Share by Country (2015-2020)
6.2 Germany Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
6.3 UK Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
6.4 France Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
6.5 Russia Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
6.6 Italy Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Lentiviral Vector In Gene Therapy Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Lentiviral Vector In Gene Therapy Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Lentiviral Vector In Gene Therapy Revenue and Market Share by Regions (2015-2020)
7.2 China Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
7.3 Japan Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
7.4 Korea Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
7.5 India Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
7.7 Australia Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Lentiviral Vector In Gene Therapy Sales, Revenue and Market Share by Country
8.1.1 South America Lentiviral Vector In Gene Therapy Sales and Market Share by Country (2015-2020)
8.1.2 South America Lentiviral Vector In Gene Therapy Revenue and Market Share by Country (2015-2020)
8.2 Brazil Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
8.3 Argentina Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Lentiviral Vector In Gene Therapy Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Lentiviral Vector In Gene Therapy Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Lentiviral Vector In Gene Therapy Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
9.3 Turkey Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
9.4 Egypt Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
9.5 South Africa Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Lentiviral Vector In Gene Therapy Sales and Market Share by Type (2015-2020)
10.2 Global Lentiviral Vector In Gene Therapy Revenue and Market Share by Type (2015-2020)
10.3 Global Lentiviral Vector In Gene Therapy Price by Type (2015-2020)
11 Global Lentiviral Vector In Gene Therapy Market Segment by Application
11.1 Global Lentiviral Vector In Gene Therapy Sales Market Share by Application (2015-2020)
11.2 Global Lentiviral Vector In Gene Therapy Revenue Market Share by Application (2015-2020)
11.3 Global Lentiviral Vector In Gene Therapy Price by Application (2015-2020)
12 Market Forecast
12.1 Global Lentiviral Vector In Gene Therapy Sales, Revenue and Growth Rate (2021-2025)
12.2 Lentiviral Vector In Gene Therapy Market Forecast by Regions (2021-2025)
12.2.1 North America Lentiviral Vector In Gene Therapy Market Forecast (2021-2025)
12.2.2 Europe Lentiviral Vector In Gene Therapy Market Forecast (2021-2025)
12.2.3 Asia-Pacific Lentiviral Vector In Gene Therapy Market Forecast (2021-2025)
12.2.4 South America Lentiviral Vector In Gene Therapy Market Forecast (2021-2025)
12.2.5 Middle East & Africa Lentiviral Vector In Gene Therapy Market Forecast (2021-2025)
12.3 Lentiviral Vector In Gene Therapy Market Forecast by Type (2021-2025)
12.3.1 Global Lentiviral Vector In Gene Therapy Sales Forecast by Type (2021-2025)
12.3.2 Global Lentiviral Vector In Gene Therapy Market Share Forecast by Type (2021-2025)
12.4 Lentiviral Vector In Gene Therapy Market Forecast by Application (2021-2025)
12.4.1 Global Lentiviral Vector In Gene Therapy Sales Forecast by Application (2021-2025)
12.4.2 Global Lentiviral Vector In Gene Therapy Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Lentiviral Vector In Gene Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Lentiviral Vector In Gene Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Lentiviral Vector In Gene Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Lentiviral Vector In Gene Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Thermo Fisher Scientific Sirion-Biotech GmbH Basic Information, Manufacturing Base and Competitors
Table 9. Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Major Business
Table 10. Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Total Revenue (USD Million) (2018-2019)
Table 11. Thermo Fisher Scientific Sirion-Biotech GmbH SWOT Analysis
Table 12. Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Product and Services
Table 13. Thermo Fisher Scientific Sirion-Biotech GmbH Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. GENEMEDI Basic Information, Manufacturing Base and Competitors
Table 15. GENEMEDI Lentiviral Vector In Gene Therapy Major Business
Table 16. GENEMEDI Lentiviral Vector In Gene Therapy Total Revenue (USD Million) (2018-2019)
Table 17. GENEMEDI SWOT Analysis
Table 18. GENEMEDI Lentiviral Vector In Gene Therapy Product and Services
Table 19. GENEMEDI Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. SignaGen Laboratories Basic Information, Manufacturing Base and Competitors
Table 21. SignaGen Laboratories Lentiviral Vector In Gene Therapy Major Business
Table 22. SignaGen Laboratories Lentiviral Vector In Gene Therapy Total Revenue (USD Million) (2018-2019)
Table 23. SignaGen Laboratories SWOT Analysis
Table 24. SignaGen Laboratories Lentiviral Vector In Gene Therapy Product and Services
Table 25. SignaGen Laboratories Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Vigene Biosciences Basic Information, Manufacturing Base and Competitors
Table 27. Vigene Biosciences Lentiviral Vector In Gene Therapy Major Business
Table 28. Vigene Biosciences Lentiviral Vector In Gene Therapy Total Revenue (USD Million) (2018-2019)
Table 29. Vigene Biosciences SWOT Analysis
Table 30. Vigene Biosciences Lentiviral Vector In Gene Therapy Product and Services
Table 31. Vigene Biosciences Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. GenTarget Basic Information, Manufacturing Base and Competitors
Table 33. GenTarget Lentiviral Vector In Gene Therapy Major Business
Table 34. GenTarget Lentiviral Vector In Gene Therapy Total Revenue (USD Million) (2018-2019)
Table 35. GenTarget SWOT Analysis
Table 36. GenTarget Lentiviral Vector In Gene Therapy Product and Services
Table 37. GenTarget Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. OriGene Technologies Basic Information, Manufacturing Base and Competitors
Table 39. OriGene Technologies Lentiviral Vector In Gene Therapy Major Business
Table 40. OriGene Technologies Lentiviral Vector In Gene Therapy Total Revenue (USD Million) (2018-2019)
Table 41. OriGene Technologies SWOT Analysis
Table 42. OriGene Technologies Lentiviral Vector In Gene Therapy Product and Services
Table 43. OriGene Technologies Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Cell Biolabs Basic Information, Manufacturing Base and Competitors
Table 45. Cell Biolabs Lentiviral Vector In Gene Therapy Major Business
Table 46. Cell Biolabs Lentiviral Vector In Gene Therapy Total Revenue (USD Million) (2018-2019)
Table 47. Cell Biolabs SWOT Analysis
Table 48. Cell Biolabs Lentiviral Vector In Gene Therapy Product and Services
Table 49. Cell Biolabs Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Takara Bio Basic Information, Manufacturing Base and Competitors
Table 51. Takara Bio Lentiviral Vector In Gene Therapy Major Business
Table 52. Takara Bio Lentiviral Vector In Gene Therapy Total Revenue (USD Million) (2018-2019)
Table 53. Takara Bio SWOT Analysis
Table 54. Takara Bio Lentiviral Vector In Gene Therapy Product and Services
Table 55. Takara Bio Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. Bluebird Bio Basic Information, Manufacturing Base and Competitors
Table 57. Bluebird Bio Lentiviral Vector In Gene Therapy Major Business
Table 58. Bluebird Bio Lentiviral Vector In Gene Therapy Total Revenue (USD Million) (2018-2019)
Table 59. Bluebird Bio SWOT Analysis
Table 60. Bluebird Bio Lentiviral Vector In Gene Therapy Product and Services
Table 61. Bluebird Bio Lentiviral Vector In Gene Therapy Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Global Lentiviral Vector In Gene Therapy Sales by Manufacturer (2018-2019) (K Units)
Table 63. Global Lentiviral Vector In Gene Therapy Revenue by Manufacturer (2018-2019) (USD Million)
Table 64. Global Lentiviral Vector In Gene Therapy Sales by Regions (2015-2020) (K Units)
Table 65. Global Lentiviral Vector In Gene Therapy Sales Market Share by Regions (2015-2020)
Table 66. Global Lentiviral Vector In Gene Therapy Revenue by Regions (2015-2020) (USD Million)
Table 67. North America Lentiviral Vector In Gene Therapy Sales by Countries (2015-2020) (K Units)
Table 68. North America Lentiviral Vector In Gene Therapy Sales Market Share by Countries (2015-2020)
Table 69. North America Lentiviral Vector In Gene Therapy Revenue by Countries (2015-2020) (USD Million)
Table 70. North America Lentiviral Vector In Gene Therapy Revenue Market Share by Countries (2015-2020)
Table 71. Europe Lentiviral Vector In Gene Therapy Sales by Countries (2015-2020) (K Units)
Table 72. Europe Lentiviral Vector In Gene Therapy Sales Market Share by Countries (2015-2020)
Table 73. Europe Lentiviral Vector In Gene Therapy Revenue by Countries (2015-2020) (USD Million)
Table 74. Asia-Pacific Lentiviral Vector In Gene Therapy Sales by Regions (2015-2020) (K Units)
Table 75. Asia-Pacific Lentiviral Vector In Gene Therapy Sales Market Share by Regions (2015-2020)
Table 76. Asia-Pacific Lentiviral Vector In Gene Therapy Revenue by Regions (2015-2020) (USD Million)
Table 77. South America Lentiviral Vector In Gene Therapy Sales by Countries (2015-2020) (K Units)
Table 78. South America Lentiviral Vector In Gene Therapy Sales Market Share by Countries (2015-2020)
Table 79. South America Lentiviral Vector In Gene Therapy Revenue by Countries (2015-2020) (USD Million)
Table 80. South America Lentiviral Vector In Gene Therapy Revenue Market Share by Countries (2015-2020)
Table 81. Middle East & Africa Lentiviral Vector In Gene Therapy Sales by Countries (2015-2020) (K Units)
Table 82. Middle East & Africa Lentiviral Vector In Gene Therapy Sales Market Share by Countries (2015-2020)
Table 83. Middle East & Africa Lentiviral Vector In Gene Therapy Revenue by Countries (2015-2020) (USD Million)
Table 84. Middle East & Africa Lentiviral Vector In Gene Therapy Revenue Market Share by Countries (2015-2020)
Table 85. Global Lentiviral Vector In Gene Therapy Sales by Type (2015-2020) (K Units)
Table 86. Global Lentiviral Vector In Gene Therapy Sales Share by Type (2015-2020)
Table 87. Global Lentiviral Vector In Gene Therapy Revenue by Type (2015-2020) (USD Million)
Table 88. Global Lentiviral Vector In Gene Therapy Revenue Share by Type (2015-2020)
Table 89. Global Lentiviral Vector In Gene Therapy Sales by Application (2015-2020) (K Units)
Table 90. Global Lentiviral Vector In Gene Therapy Sales Share by Application (2015-2020)
Table 91. Global Lentiviral Vector In Gene Therapy Sales Forecast by Regions (2021-2025) (K Units)
Table 92. Global Lentiviral Vector In Gene Therapy Market Share Forecast by Regions (2021-2025)
Table 93. Global Lentiviral Vector In Gene Therapy Sales Forecast by Type (2021-2025) (K Units)
Table 94. Global Lentiviral Vector In Gene Therapy Market Share Forecast by Type (2021-2025)
Table 95. Global Lentiviral Vector In Gene Therapy Sales Forecast by Application (2021-2025)
Table 96. Global Lentiviral Vector In Gene Therapy Market Share Forecast by Application (2021-2025)
Table 97. Direct Channel Pros & Cons
Table 98. Indirect Channel Pros & Cons
Table 99. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Lentiviral Vector In Gene Therapy Picture
Figure 2. Global Sales Market Share of Lentiviral Vector In Gene Therapy by Type in 2019
Figure 3. Retrovirus (RV) Picture
Figure 4. Adenovirus (AdV) Picture
Figure 5. Adeno-associated Virus (AAV) Picture
Figure 6. Lentiviral Vector In Gene Therapy Sales Market Share by Application in 2019
Figure 7. Hospital Picture
Figure 8. Clinic Picture
Figure 9. Research Institution Picture
Figure 10. Others Picture
Figure 11. Global Lentiviral Vector In Gene Therapy Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Lentiviral Vector In Gene Therapy Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Lentiviral Vector In Gene Therapy Sales Market Share by Manufacturer in 2019
Figure 32. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Lentiviral Vector In Gene Therapy Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Lentiviral Vector In Gene Therapy Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Lentiviral Vector In Gene Therapy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Regions (2015-2020)
Figure 39. Global Lentiviral Vector In Gene Therapy Revenue Market Share by Regions in 2018
Figure 40. North America Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
Figure 41. Europe Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
Figure 43. South America Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020)
Figure 45. North America Lentiviral Vector In Gene Therapy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Lentiviral Vector In Gene Therapy Sales Market Share by Countries (2015-2020)
Figure 47. North America Lentiviral Vector In Gene Therapy Sales Market Share by Countries in 2018
Figure 48. North America Lentiviral Vector In Gene Therapy Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Lentiviral Vector In Gene Therapy Revenue Market Share by Countries in 2018
Figure 50. United States Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Lentiviral Vector In Gene Therapy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Lentiviral Vector In Gene Therapy Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Lentiviral Vector In Gene Therapy Revenue Market Share by Countries in 2019
Figure 56. Germany Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Lentiviral Vector In Gene Therapy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Lentiviral Vector In Gene Therapy Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Lentiviral Vector In Gene Therapy Revenue Market Share by Regions 2019
Figure 64. China Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Lentiviral Vector In Gene Therapy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Lentiviral Vector In Gene Therapy Sales Market Share by Countries in 2019
Figure 71. South America Lentiviral Vector In Gene Therapy Revenue Market Share by Countries in 2019
Figure 72. Brazil Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Lentiviral Vector In Gene Therapy Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Lentiviral Vector In Gene Therapy Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Lentiviral Vector In Gene Therapy Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Lentiviral Vector In Gene Therapy Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Lentiviral Vector In Gene Therapy Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Lentiviral Vector In Gene Therapy Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Lentiviral Vector In Gene Therapy Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Lentiviral Vector In Gene Therapy Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Lentiviral Vector In Gene Therapy Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Lentiviral Vector In Gene Therapy Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel
ムコ多糖症（MPS）遺伝子治療の世界市場（～2026年） Mucopolysaccharidosis consists of a group of more than 40 genetic disorders that forms a part of lysosomal storage disease. They are caused by an inherited deficiency of an enzyme involved in the degradation of acid glycosaminoglycans (GAGs), which was previously known as mucopolysaccharidosis. All …- 卵巣がん遺伝子治療の世界市場（～2026年） Ovarian cancer occurs and arises from several types of cells within the ovary, and it has the lowest survival rate of all gynecological cancers. Among many types, epithelial ovarian cancer (EOC) is the most common ovarian cancer, whereas ovarian low malignant potential tumor (OLMPT), germ cell tumor…
- 加齢黄斑変性症（AMD）遺伝子治療の世界市場（～2026年） Macular degeneration is a condition in which, macula, a part of the retina, gets damaged or deteriorated. This condition usually affects individuals who are aged 50 years and above and therefore, it is called age-related macular degeneration (AMD). AMD is the leading cause of vision loss and is dire…
- ウイルスベクター製造の世界市場（～2026年） Viral vectors represent one of the primary tools, which can be used to deliver the genetic material into cells. Viral vectors can be utilized in gene therapy for the treatment of different diseases, such as heart defects, metabolic diseases, cancer, and neurodegenerative disorders. Viral vectors bas…
- がん遺伝子治療の世界市場（～2026年） Cancer could be defined as uncontrolled cell growth in the body leading to organ malfunction. If untreated, it can lead to death. Uncontrolled growth of cell is managed by the body in several ways, one of them is by deploying white blood cells to detect and eradicate these cancerous cells. It has be…